Abbott India Limited vs CreditAccess Grameen Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and CreditAccess Grameen Limited (Microfinance and financial services) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Head-to-head highlights
| Metric | Abbott India Limited | CreditAccess Grameen Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Roughly INR 4,000 crore to INR 5,500 crore, unverified | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Roughly INR 1,000 crore to INR 1,500 crore, unverified | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
CreditAccess Grameen Limited
Microfinance and financial services · India
CreditAccess Grameen Limited is an Indian microfinance institution focused on providing small-ticket financial services to low-income households, especially women in rural and semi-urban areas. It operates as a non-banking financial company and offers credit and related financial products through a branch-led model.
Verified financials
No source-verified financials available.
Strengths
- Established rural and semi-urban distribution network
- Focused expertise in microfinance underwriting and collections
- Strong brand recognition in core operating regions
- Access to public equity and institutional debt markets
Weaknesses
- High exposure to economically vulnerable borrower segments
- Concentration in microfinance lending
- Susceptibility to regional credit shocks and collection disruptions
- Dependence on regulatory and funding conditions
Opportunities
- Expansion into underserved geographies
- Cross-selling insurance and broader financial products
- Digital tools to improve underwriting and collections
- Growing demand for formal credit among low-income households
Threats
- Regulatory tightening in microfinance
- Rising borrower over-indebtedness in some markets
- Credit losses from weather, health, or economic shocks
- Competition from banks and fintech-enabled lenders
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs CreditAccess Grameen Limited: which company leads overall?
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Digital Payments Market — Intelligence Report
Embedded Finance & Banking-as-a-Service (BaaS) Market — Intelligence Report
Global Digital Payments & Real-Time Rails Market — Intelligence Report
Global Stablecoin Payments and Settlement Infrastructure Market — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs CreditAccess Grameen Limited's verified data. Modeled estimates — not investment advice.
Not enough data yet to generate insights.